SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,383 | -31.3% | 756 | -1.7% | 0.00% | – |
| Q2 2023 | $7,836 | -39.6% | 769 | -46.2% | 0.00% | – |
| Q1 2023 | $12,970 | +153.0% | 1,430 | +100.0% | 0.00% | – |
| Q4 2022 | $5,127 | +2.5% | 715 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 715 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 715 | -19.6% | 0.00% | – |
| Q1 2022 | $5,000 | -99.8% | 889 | -99.6% | 0.00% | – |
| Q1 2018 | $2,480,000 | +2.6% | 200,000 | 0.0% | 0.00% | – |
| Q4 2017 | $2,418,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,561,474 | $17,166,000 | 4.25% |
| AIGH Capital Management LLC | 1,346,724 | $6,491,000 | 1.71% |
| Worth Venture Partners, LLC | 335,985 | $1,784,000 | 1.05% |
| Ikarian Capital, LLC | 884,008 | $4,261,000 | 0.78% |
| Orbimed Advisors | 4,797,148 | $23,122,000 | 0.42% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $13,014,000 | 0.23% |
| Sandy Cove Advisors, LLC | 10,592 | $51,000 | 0.05% |
| Belvedere Trading LLC | 239,219 | $1,270,000 | 0.04% |
| IPG Investment Advisors LLC | 14,300 | $69,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $637,000 | 0.02% |